IMVT (STOCKS)
Immunovant, Inc. Common Stock
$25.940000
-0.740000 (-2.77%)
Prev close: $26.680000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Eric Venker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,276.57M
- Employees
- 362
- P/E (TTM)
- -9.67
- P/B (TTM)
- 5.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Operating Expenses | $487.17M |
| Income/Loss From Continuing Operations After Tax | -$464.20M |
| Income/Loss From Continuing Operations Before Tax | -$460.56M |
| Income Tax Expense/Benefit | $3.64M |
| Net Income/Loss | -$464.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$464.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$464.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.67 |
| Diluted Earnings Per Share | -$2.67 |
| Basic Average Shares | 180,427,630 |
| Diluted Average Shares | 180,427,630 |
| Assets | $1.05B |
| Current Assets | $1.04B |
| Prepaid Expenses | $46.77M |
| Other Current Assets | $996.17M |
| Noncurrent Assets | $9.45M |
| Fixed Assets | $531.00K |
| Other Non-current Assets | $8.92M |
| Liabilities | $66.26M |
| Current Liabilities | $66.26M |
| Accounts Payable | $8.62M |
| Other Current Liabilities | $57.64M |
| Noncurrent Liabilities | $0.00 |
| Equity | $986.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $986.14M |
| Liabilities And Equity | $1.05B |
| Net Cash Flow From Operating Activities | -$422.89M |
| Net Cash Flow From Operating Activities, Continuing | -$422.89M |
| Net Cash Flow From Investing Activities | -$280.76M |
| Net Cash Flow From Investing Activities, Continuing | -$280.07M |
| Net Cash Flow From Financing Activities | $1.04B |
| Net Cash Flow From Financing Activities, Continuing | $1.04B |
| Exchange Gains/Losses | $201.00K |
| Net Cash Flow | $338.60M |
| Net Cash Flow, Continuing | $338.40M |
| Comprehensive Income/Loss | -$465.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$465.48M |
| Other Comprehensive Income/Loss | -$465.48M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.28M |